AGY Therapeutics is a pioneering biopharmaceutical company dedicated to the discovery, development, and commercialization of revolutionary treatments for diseases of the central nervous system. With a primary focus on conditions such as bipolar disorder, AGY Therapeutics is at the forefront of scientific innovation and medical breakthroughs that have the potential to transform the lives of millions of people worldwide.